Health Canada inspection
Mitsubishi Tanabe Pharma Corporation: Health Canada inspection of Jun 29, 2021
Health Canada · GVP · rating C
Key facts
| Establishment | Mitsubishi Tanabe Pharma Corporation |
|---|---|
| City | Chuo-Ku |
| Province | Osaka |
| Country | Japan |
| Program | GVP |
| Start date | Jun 23, 2021 |
| End date | Jun 29, 2021 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: